Download Guidelines (updated 5 March 2012);
The University of Maryland Research and Innovation Seed Program
The University of Maryland, College Park (UMD) and Baltimore (UMB) campuses are pleased to announce a new two-pronged joint Research and Innovation Seed Grant Program for 2012. The intent of this new initiative is to promote the structured collaboration between UMD and UMB and to advance the institutions’ joint goals in research and innovation.
Our new UM Research and Innovation Seed Program will:
- Foster creative teams of investigators working across disciplinary boundaries and campuses;
- Support new research foci and the underlying basic science to pursue future health care improvements and/or technologies; and
- Stimulate submission of innovative basic and translational science research proposals to federal, public or private funding agencies.
Projects that promote and further our collaborative interests will be given preference in this year’s review, including, but not limited to: those in the fields of personalized medicine, bioinformatics, bioengineering, complex therapeutics, health care optimization, public health informatics, health information technology and health science research.
The two seed grant categories are:
- Basic and early stage translational research; and
- Complex therapeutics in conjunction with the Institute for Bioscience and Biotechnology Research (IBBR) in Shady Grove.
To be considered for either of the two seed grant opportunities, a proposal meeting the attached guidelines must be submitted no later than April 16, 2012. For applications in category B, a letter of intent is required by April 2nd (submit to grants@ibbr.umd.edu). Basic and Translational Science proposals should address the scientific merits of the proposed research and identify and justify NIH, NSF or other funding programs that would be receptive of a full proposal that contains preliminary results obtained. Complex Therapeutics proposals should emphasize one (or more) of the following focus areas for development of biologic drugs: immune response, bioanalytical characteristics, posttranslational modifications, production cell efficiency and development. Further details are in the appendices.
The number of awards will depend on the quantity and quality of proposals received, as well as their proposed budgets. The program will have significant financial support from many sources. The maximum per grant award is $100K. In some cases, these seed grant opportunities have specific criteria and guidelines, and all will have separate peer review panels. (See appendices.)
Individual investigators may submit multiple proposals but can participate as a PI on only one awarded proposal. The top-ranked proposal after peer review will be the one eligible for funding. Investigators can serve as collaborators on an unlimited number of proposals. Past awardees remain eligible for this year’s competition.
If you have detailed questions regarding application guidelines, please contact Anne Geronimo, UMD, geronimo@umd.edu; Sue Hobbs, UMB/SOM, SHobbs@som.umaryland.edu ; or Debra Weinstein, IBBR, Debbie@umd.edu;
Proposals for category A must be submitted to www.umresearch.umd.edu/sgp as a combined pdf file prior to 5:00 PM EST April 16, 2012.
Proposals for category B must be submitted to grants@ibbr.umd.edu by 5:00pm EST April 16, 2012 (LOI due April 2).
University of Maryland Division of Research
2133 Lee Building, College Park, MD 20742-5141
Contact: umseedadmin@umd.edu
© Copyright 2007-2011
All Rights Reserved